|4Jan 14, 3:15 PM ET

LIGAND PHARMACEUTICALS INC 4

4 · LIGAND PHARMACEUTICALS INC · Filed Jan 14, 2004

Insider Transaction Report

Form 4
Period: 2004-01-12
Transactions
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2004-01-122,4940 total
    Exercise: $9.21From: 1995-05-24Exp: 2004-05-24Common Stock (2,494 underlying)
  • Exercise/Conversion

    Common Stock

    2004-01-12$5.81/sh+8,118$47,18624,494 total
  • Exercise/Conversion

    Common Stock

    2004-01-12$9.80/sh+5,625$55,12516,376 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2004-01-128,1180 total
    Exercise: $5.81From: 1996-05-17Exp: 2005-05-17Common Stock (8,118 underlying)
  • Exercise/Conversion

    Common Stock

    2004-01-12$9.21/sh+2,494$22,97110,751 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2004-01-125,6250 total
    Exercise: $9.80From: 1995-05-25Exp: 2004-05-25Common Stock (5,625 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    12,001
Footnotes (1)
  • [F1]The shares were exercised and not sold.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT